SI9420007A - Novel phenylethyl and phenylpropylamines - Google Patents

Novel phenylethyl and phenylpropylamines Download PDF

Info

Publication number
SI9420007A
SI9420007A SI9420007A SI9420007A SI9420007A SI 9420007 A SI9420007 A SI 9420007A SI 9420007 A SI9420007 A SI 9420007A SI 9420007 A SI9420007 A SI 9420007A SI 9420007 A SI9420007 A SI 9420007A
Authority
SI
Slovenia
Prior art keywords
branched
general formula
compound
amino
alkyl group
Prior art date
Application number
SI9420007A
Other languages
English (en)
Slovenian (sl)
Inventor
Stefan Bengtsson
Sven Hellberg
Nina Mohell
Lian Zgang
Gerd Hallnemo
David Jackson
Bengt Ulff
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SI9420007A publication Critical patent/SI9420007A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
SI9420007A 1993-10-07 1994-09-16 Novel phenylethyl and phenylpropylamines SI9420007A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303274A SE9303274D0 (sv) 1993-10-07 1993-10-07 Novel phenylethyl and phenylproplamines

Publications (1)

Publication Number Publication Date
SI9420007A true SI9420007A (en) 1996-04-30

Family

ID=20391336

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420007A SI9420007A (en) 1993-10-07 1994-09-16 Novel phenylethyl and phenylpropylamines

Country Status (31)

Country Link
US (1) US5693630A (zh)
EP (1) EP0672032B1 (zh)
JP (1) JPH08504835A (zh)
KR (1) KR950704236A (zh)
CN (1) CN1048718C (zh)
AT (1) ATE161823T1 (zh)
AU (1) AU680303B2 (zh)
BR (1) BR9405632A (zh)
CA (1) CA2150005A1 (zh)
CZ (1) CZ148595A3 (zh)
DE (1) DE69407751T2 (zh)
DK (1) DK0672032T3 (zh)
EE (1) EE03214B1 (zh)
ES (1) ES2111959T3 (zh)
FI (1) FI952772A0 (zh)
GR (1) GR3026484T3 (zh)
HU (1) HUT73774A (zh)
IL (1) IL111133A (zh)
IS (1) IS4204A (zh)
LT (1) LT3920B (zh)
LV (1) LV10862B (zh)
NO (1) NO305947B1 (zh)
NZ (1) NZ274273A (zh)
PL (1) PL179011B1 (zh)
RU (1) RU2133735C1 (zh)
SE (1) SE9303274D0 (zh)
SI (1) SI9420007A (zh)
SK (1) SK67295A3 (zh)
TW (1) TW338036B (zh)
WO (1) WO1995009835A1 (zh)
ZA (1) ZA947209B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1289965B1 (en) * 2000-05-25 2005-10-26 F. Hoffmann-La Roche Ag Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
US20040235920A1 (en) * 2001-09-12 2004-11-25 Gerd Bartoszyk Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
IL157751A0 (en) 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
IL156203A0 (en) * 2003-05-29 2003-12-23 Yissum Res Dev Co Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7644E (fr) 1903-08-11 1907-09-17 Chappee Et Fils Soc Nouveau système d'assainissement des villes
DE1518375A1 (de) * 1965-06-08 1969-08-14 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 2-Amino-halogenbenzylaminen
FR7644M (zh) * 1968-06-24 1970-02-02
DE2345423A1 (de) * 1973-09-08 1975-03-20 Thomae Gmbh Dr K Neue substituierte phenylaethylaminderivate, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu deren herstellung
AT330777B (de) * 1973-09-08 1976-07-26 Thomae Gmbh Dr K Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
US4021558A (en) * 1973-09-08 1977-05-03 Boehringer Ingelheim Gmbh 1,3-Dioxo-2-[(methoxyphenethyl-amino)-alkyl]-4,4-dimethyl-isoquinolines and salts thereof useful as hypotensive agents
JPS5414956A (en) * 1977-07-04 1979-02-03 Sumitomo Chem Co Ltd Novel 3-amino-4-homoisotwistan derivative
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2608157B1 (fr) * 1986-12-11 1989-09-08 Roussel Uclaf Nouveaux derives de l'azaspirodecane, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant et intermediaires
NO170790C (no) 1986-12-12 1992-12-02 Ceraver Fremgangsmaate for fremstilling av lynavleder

Also Published As

Publication number Publication date
TW338036B (en) 1998-08-11
FI952772A (fi) 1995-06-06
NO952232D0 (no) 1995-06-06
BR9405632A (pt) 1999-05-25
CA2150005A1 (en) 1995-04-13
IS4204A (is) 1995-04-08
SK67295A3 (en) 1996-09-04
EP0672032B1 (en) 1998-01-07
PL309189A1 (en) 1995-09-18
SE9303274D0 (sv) 1993-10-07
PL179011B1 (pl) 2000-07-31
RU95112451A (ru) 1997-04-20
HU9501643D0 (en) 1995-08-28
HUT73774A (en) 1996-09-30
DE69407751D1 (de) 1998-02-12
ZA947209B (en) 1995-07-07
EE03214B1 (et) 1999-08-16
NZ274273A (en) 1996-10-28
DK0672032T3 (da) 1998-05-04
FI952772A0 (fi) 1995-06-06
AU7825694A (en) 1995-05-01
AU680303B2 (en) 1997-07-24
GR3026484T3 (en) 1998-06-30
ES2111959T3 (es) 1998-03-16
EP0672032A1 (en) 1995-09-20
IL111133A0 (en) 1994-12-29
NO305947B1 (no) 1999-08-23
IL111133A (en) 1998-12-27
LV10862A (lv) 1995-10-20
RU2133735C1 (ru) 1999-07-27
WO1995009835A1 (en) 1995-04-13
DE69407751T2 (de) 1998-04-16
ATE161823T1 (de) 1998-01-15
JPH08504835A (ja) 1996-05-28
CN1048718C (zh) 2000-01-26
LV10862B (en) 1996-08-20
US5693630A (en) 1997-12-02
LT95059A (en) 1995-10-25
CN1115575A (zh) 1996-01-24
KR950704236A (ko) 1995-11-17
NO952232L (no) 1995-07-18
LT3920B (en) 1996-04-25
CZ148595A3 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
KR890000566B1 (ko) 1-헤테로아릴-4-[(2,5-피롤리딘디온-1-일)알킬]피페라진유도체 및 그 제조방법
BR112020014810A2 (pt) Inibidores de endonuclease dependentes de capa
GB2048852A (en) Derivatives of glycinamide
EP3215510A1 (en) Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
DE4243287A1 (de) N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
CA1103671A (fr) Procede de preparation de nouvelles quinazolinones
SK147897A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
SI9420007A (en) Novel phenylethyl and phenylpropylamines
JPH0747585B2 (ja) イソオキサゾール誘導体
FR2664269A1 (fr) Nouveaux derives n-substitues d'alpha-mercapto alkylamines, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
JPH06506956A (ja) ピリドンの新規な誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
CA3032586A1 (en) Biaryl compounds and use thereof for modulating a kinase cascade
US20040167120A1 (en) Novel Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
SU1402251A3 (ru) Способ получени производных 3-фенил-2-пропенамина в виде геометрических изомеров или их смесей, а также фармакологически приемлемых солей
FI90775C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bisyklisten siltaimidiyhdisteiden valmistamiseksi
US3647802A (en) 2-amino-4-aryl-3 4-dihydroquinolines
TW201713628A (zh) 一種雄性激素受體抑制劑的結晶形式及其製備方法
JPS5817473B2 (ja) Ｎ − フクソカンプルビンサンアミドノセイホウ
US3185705A (en) 2-phenyl-5, 5-di-esters and di-amides of 2-pyrroline and the corresponding pyrrolidines
ZA200300262B (en) Carboxamide compounds and their use as antagonists of a human 11CBy receptor.
Weis et al. Dihydropyrimidines. 16. Stability and enamine-imine tautomerism in 1, 2-and 2, 5-dihydropyrimidines
IE48431B1 (en) Substituted dihydropyridine ureas,process for preparing the same and pharmaceutical compositions containing them
OTOMASU et al. Synthesis of Condensed Quinoxalines. II. A New Synthesis of Pyrrolo-[2, 3-b] quinoxalines
AU8512198A (en) Process for converting propargylic amine-n-oxides to enaminones
AT387773B (de) Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten